IRIS
Russo, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.430
AS - Asia 2.108
EU - Europa 883
SA - Sud America 531
AF - Africa 44
OC - Oceania 1
Totale 5.997
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.339
SG - Singapore 929
IT - Italia 541
CN - Cina 424
BR - Brasile 403
VN - Vietnam 237
IN - India 201
HK - Hong Kong 107
DE - Germania 74
BD - Bangladesh 57
GB - Regno Unito 51
NL - Olanda 50
AR - Argentina 44
FI - Finlandia 38
CA - Canada 37
MX - Messico 31
ID - Indonesia 25
JP - Giappone 22
EC - Ecuador 20
ES - Italia 19
IQ - Iraq 19
ZA - Sudafrica 18
CL - Cile 17
CO - Colombia 15
RU - Federazione Russa 15
PK - Pakistan 14
PL - Polonia 14
CZ - Repubblica Ceca 12
SE - Svezia 12
VE - Venezuela 11
FR - Francia 10
PE - Perù 10
TR - Turchia 10
AE - Emirati Arabi Uniti 8
AT - Austria 8
MA - Marocco 8
PY - Paraguay 8
JM - Giamaica 7
RO - Romania 7
CR - Costa Rica 6
EG - Egitto 6
LT - Lituania 6
SA - Arabia Saudita 6
TH - Thailandia 6
UZ - Uzbekistan 6
IL - Israele 5
KE - Kenya 5
NP - Nepal 5
UA - Ucraina 5
JO - Giordania 4
BG - Bulgaria 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
PH - Filippine 3
RS - Serbia 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AM - Armenia 1
BE - Belgio 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
IE - Irlanda 1
KH - Cambogia 1
KI - Kiribati 1
KR - Corea 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
OM - Oman 1
TG - Togo 1
Totale 5.997
Salva come PNG Salva come JPEG
Città #
San Jose 699
Ashburn 323
Singapore 304
Santa Clara 192
Dallas 186
Bengaluru 165
Hefei 163
Milan 152
Beijing 101
Hong Kong 100
Ho Chi Minh City 88
Munich 64
Hanoi 55
Lawrence 50
Princeton 50
Los Angeles 37
Rome 35
São Paulo 32
Chicago 31
Turku 28
Chandler 27
London 23
New York 23
Wilmington 22
Naples 17
San Francisco 17
The Dalles 17
Chennai 16
Des Moines 15
Montreal 15
Brooklyn 14
Da Nang 14
Palermo 14
Tokyo 14
Columbus 13
Olomouc 12
Warsaw 12
Amsterdam 11
Baghdad 11
Boardman 11
Council Bluffs 10
Rio de Janeiro 10
Stockholm 10
Bari 9
Helsinki 9
Johannesburg 9
Phoenix 9
Atlanta 8
Brasília 8
Cosenza 8
Mexico City 8
Padova 8
Denver 7
Haiphong 7
Hải Dương 7
Joinville 7
Porto Alegre 7
Quito 7
Rende 7
Belo Horizonte 6
Boston 6
Buffalo 6
Dhaka 6
Guayaquil 6
Jakarta 6
Maryland Heights 6
Orem 6
Salvador 6
Santiago 6
Biên Hòa 5
Bologna 5
Lima 5
Manchester 5
Nairobi 5
Norwalk 5
San José 5
Tashkent 5
Thái Bình 5
Urbisaglia 5
Amman 4
Ankara 4
Aversa 4
Bogotá 4
Cairo 4
Can Tho 4
Caracas 4
Curitiba 4
Florence 4
Guarulhos 4
Itajaí 4
Kingston 4
Medellín 4
Miami 4
Philadelphia 4
Pune 4
Ribeirão Preto 4
San Nicola Manfredi 4
Taranto 4
Turin 4
West Jordan 4
Totale 3.522
Salva come PNG Salva come JPEG
Nome #
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 96
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 81
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 78
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 76
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 73
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 68
The role of Gram-negative bacteria in skin and soft tissue infections 64
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 63
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience 62
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: A retrospective observational multicenter study 62
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the “Magna Graecia” University Unit of Infectious Diseases: A Didascalic Review 61
Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study 61
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19? 60
Severe Hemodynamic Instability in a Young Pregnant Woman with Massive Pericardial Effusion and Pulmonary Embolism Secondary to Primary Mediastinal Non-Hodgkin's Lymphoma 60
Post-traumatic stress symptoms in healthcare workers dealing with the covid-19 pandemic: A systematic review 60
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 60
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 54
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections 54
Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence 53
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 53
A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment 52
The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study) 52
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 51
Impact of Multiplex PCR on Diagnosis of Bacterial and Fungal Infections and Choice of Appropriate Antimicrobial Therapy. 50
Lights and Shadows of Long COVID: Are Latent Infections the Real Hidden Enemy? 50
Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic 49
Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study 48
Preoperative right ventricular strain as an early predictor of perioperative cardiac failure in patients undergoing mitral surgery: An exploratory study 48
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 48
Incipient tuberculosis: a comprehensive overview 47
Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study 47
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone 47
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience 46
INTERLEUKIN-62/LYMPHOCYTE AS A PROPOSED PREDICTIVE INDEX FOR COVID-19 PATIENTS TREATED WITH MONOCLONAL ANTIBODIES 46
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain 46
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 46
Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut Microbiota 45
Evolution of in-hospital patient characteristics and predictors of death in the COVID-19 pandemic across four waves: are they moving targets with implications for patient care? 44
Lights and Shadows of Sepsis Management: Challenges and Future Perspectives 44
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria 44
A hypothesis-generating study of the combination of aspirin plus macrolides in patients with severe community-acquired pneumonia 44
Role of Low-Molecular-Weight Heparin in Hospitalized Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study 44
Clinical features, therapy and outcome of patients hospitalized or not for nursing-home acquired pneumonia 44
Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies 43
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study 43
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 43
Early antibiotic treatment in emergency department: the critical balance 43
Role of oral nystatin prophylaxis in cardiac surgery with prolongedextracorporeal circulation 42
A case of Lactobacillus casei bacteraemia associated with aortic dissection: Is there a link? 42
In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience 41
Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections 41
Clinical features and outcome of difficult-to-treat infections in a high-intensity medical care ward 41
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 41
Covid-19 sequelae in working age patients: A systematic review 41
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study (BMC Infectious Diseases, (2022), 22, 1, (793), 10.1186/s12879-022-07774-9) 40
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae 40
Procalcitonin in daily clinical practice: an evergreen tool also during a pandemic 40
Inhaled Liposomal Antimicrobial Delivery in Lung Infections 40
Comparison of septic shock due to multidrug-resistant acinetobacter baumannii or klebsiella pneumoniae carbapenemase-producing k. Pneumoniae in intensive care unit patients 40
Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis 40
Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia? 40
Risk factors for the development of hospital-acquired pneumonia in patients with carbapenem-resistant Acinetobacter baumannii respiratory colonization and the role of multisite colonization: a multicenter retrospective study. 39
Effect of n-acetylcysteine administration on 30-day mortality in critically ill patients with septic shock caused by carbapenem-resistant klebsiella pneumoniae and acinetobacter baumannii: A retrospective case-control study 39
From Spores to Solutions: A Comprehensive Narrative Review on Mucormycosis 38
OMIC INSIGHTS INTO VARIOUS CEFTAZIDIME-AVIBACTAM-RESISTANT KLEBSIELLA PNEUMONIAE ISOLATES FROM TWO SOUTHERN ITALIAN REGIONS 38
Surgical Versus Conservative Treatment of Post-Sternotomy Mediastinitis: Clinical Characteristics, Microbiology, and Outcomes from a 10-Year Cohort 38
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 37
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia 37
Role of procalcitonin in bacteremic patients and its potential use in predicting infection etiology 36
Efficacy of remdesivir-containing therapy in hospitalized COVID-19 patients: A prospective clinical experience 36
Daptomycin serum levels in critical patients undergoing continuous renal replacement 36
Chronic Suppressive Antibiotic Treatment for Staphylococcal Bone and Joint Implant–Related Infections 36
Intravenous Fosfomycin: The Underdog Player in the Treatment of Carbapenem-resistant Acinetobacter baumannii Infections 35
SARS-CoV-2 pandemic, influenza, and influenza-like illness epidemics: Allies or enemies? 35
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study 35
Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study 35
Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment 35
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 34
Circulation of a Unique Klebsiella pneumoniae Clone, ST147 NDM-1/OXA-48, in Two Diverse Hospitals in Calabria (Italy) 34
Candidemia subsequent to severe infection due to Clostridium difficile: Is there a link? 34
Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and h1n1 influenza 34
Multidrug-resistant klebsiella pneumoniae: Challenges for treatment, prevention and infection control 34
High Incidence of Candidemia in Critically Ill COVID-19 Patients Supported by Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Study 33
COVID-19 and kidney transplantation: an Italian Survey and Consensus 33
Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections 33
Broadly reactive human CD4+ T cells against Enterobacteriaceae are found in the naïve repertoire and are clonally expanded in the memory repertoire 33
Efficacy of daptomycin-containing regimen for treatment of staphylococcal or enterococcal vertebral osteomyelitis: A prospective clinical experience 33
Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission 33
New advances in management and treatment of cardiac implantable electronic devices infections 32
Time to Effective Therapy Is an Important Determinant of Survival in Bloodstream Infections Caused by Vancomycin-Resistant Enterococcus spp 32
CAP and HCAP are different? An unresolved question 32
Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with e coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance 32
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 32
Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients With Liver Cirrhosis 32
Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets 31
First report of spondylodiscitis caused by Bacillus circulans in an immunocompetent patient: Clinical case and review of the literature 31
Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection 31
Candidaemia after heart valve replacement surgery: Recurrence as prosthetic valve endocarditis is an expected over one-year complication 31
Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae 31
Risk factors and outcomes for bloodstream infections secondary to Clostridium difficile infection 31
Totale 4.453
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.108
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022142 0 0 0 0 0 0 48 25 25 19 25 0
2022/2023336 104 7 15 12 15 2 3 20 109 10 28 11
2023/2024327 45 38 17 32 34 40 26 11 8 14 36 26
2024/20251.500 231 9 25 47 105 213 45 57 212 77 172 307
2025/20263.863 147 526 386 590 425 160 465 184 456 277 178 69
2026/202735 35 0 0 0 0 0 0 0 0 0 0 0
Totale 6.203